ClinVar Miner

Submissions for variant NM_020433.5(JPH2):c.1852A>G (p.Thr618Ala)

gnomAD frequency: 0.00017  dbSNP: rs376612687
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000766783 SCV000590375 likely benign not provided 2021-03-23 criteria provided, single submitter clinical testing Has not been previously reported as pathogenic or benign to our knowledge; Reported in ClinVar (ClinVar Variant ID# 432626; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000498785 SCV000711667 likely benign not specified 2018-06-06 criteria provided, single submitter clinical testing p.Thr618Ala in exon 4 of JPH2: This variant is not expected to have clinical si gnificance because it has been identified in 0.04% (51/117444) of European chrom osomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute. org; dbSNP rs376612687) and computational prediction tools and conservation anal ysis suggest that the p.Thr618Ala variant may not impact the protein. ACMG/AMP C riteria applied: BS1; BP4.
Ambry Genetics RCV000619678 SCV000739950 uncertain significance Cardiovascular phenotype 2022-07-26 criteria provided, single submitter clinical testing The p.T618A variant (also known as c.1852A>G), located in coding exon 4 of the JPH2 gene, results from an A to G substitution at nucleotide position 1852. The threonine at codon 618 is replaced by alanine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV000696678 SCV000825251 uncertain significance Hypertrophic cardiomyopathy 2024-01-08 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 618 of the JPH2 protein (p.Thr618Ala). This variant is present in population databases (rs376612687, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with JPH2-related conditions. ClinVar contains an entry for this variant (Variation ID: 432626). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Clinical Genetics, Academic Medical Center RCV000766783 SCV001920885 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000766783 SCV001951461 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000766783 SCV001968790 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.